1480-1481 / 2001
Disease progression free survival dependent
on PSA level, preoperativ parameter
< 4ng/ml
5 years progression
Cancer survival < 10ng/ml vs
free probabiity
86%
>10ng/ml
10 years
vs.55%
vs 28%.
Bianco FJ IJROBP 2005